Cmp – 39
Market Cap – 1750cr
Face value- Rs.2
Book Value – 6.75
52wk High/Low – 41.75/13.80
5 years High/Low – 44.45( jan 2018)/7.20( March’20)
ROE – 12.50% ( Atmost at 10 year High)
ROCE – 10.25% ( Increasing Cont from last few years)
Best To Accmulate – 32 To 36 zone
TECHNICALLY- Once it closes above 45.55 & Suatains can see clean upmove
Test Levels # 75 ( 12 to 18 months)/ 110 ( 18 To 30 Months)/ 200+ ( 36 To 48 Months)
S/L – As per Risk or 25.95 on closing basis

Management About Growth – Very Optimistic about Next 5 to 7 years ( From 4 billion To 40 billion dollar company)
🔅Morepen Lab is three-and-a-half decade old company, It has always aspired to be an organisation with tangible, visible differences where every individual action is inspired by a deep, humbling desire to make a difference to the lives we touch. Its state-of-art manufacturing facility in the picturesque environs of Baddi comprises a scientifically integrated complex of 10 plants, each with a specific product profile. The company’s extensive R&D facilities and factories are manned by a dedicated team of professionals who ensure stringent quality standards. With a strong global presence, Morepen exports to over 75 countries with certifications from all major regulatory authorities like USFDA, WHO GMP, EU GMP. Our domestic products under the brand name, Dr. Morepen and Gubb world have a huge range of healthcare, grooming and OTC products trusted by over 100 million consumers.



Govt. of India recognized R&D Centre with focus on anti-diabetic, anti-depressants and anti-coagulant.
Over 25 new molecules in advance stage of development with non-infringing process, excellent impurity profile and complete documentation.
Largest producer of Montelukast in the world with 60 MT capacity per annum
Over 90% market share of Generic Loratadine in US Market with 150MT capacity per annum.
The top lead player manufacturer of block buster drug, Atorvastatin with
market size of US$18 bn




🔅25+ New molecules in Advance stage of Development
🔅WHO,USFDA Approved Quality controlled process.
🔅54+ patents awarded Globally and Regionally.
🔅45+ Drug master Files published for all API’s with international standard
Specialized Chemical Synthesis
- Acetylation/ Alkylation Reaction
- Amine/ Hydroxy Deprotection
- Amino Acid Coupling
- Ester Hydrolysis
- Chiral Synthesis
- Condensation Reaction
- Cyanation Reaction
- Grignard Reaction
- Friedel Craft Reaction
- Hetero Cyclization
- High pressure Hydrogenation
- α, β-Enzymatic Oxidation
- Reduction Reaction
- Esterification
- Nucleophilic Substitution
- Oxidation Reaction


Disclaimer – All views expressed are personal and only for educational and study purpose. Consult your financial advisor before investing or taking any position based on above article.
Can you update Regarding IT stock dollar is on top and IT stock down near 52 week low
When it will be start upward journey.
Can pl. Update can it again top in Jan-23
Because every year in Jan. all IT stock at top or new heigh
Pl. Update in telegram site
Thank
Nimesh Patel
LikeLiked by 1 person
Here market is concerned abiut 2-3 things for IT Sector
1)Revenue growth Impact due to fears of Recession in US and Europe.
2)Margin Impact Due to wage increase and Shortage of Talent.
LikeLiked by 1 person